GI
NAMS icon

GAMMA Investing’s NewAmsterdam Pharma NAMS Stock Holding History

GAMMA Investing’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305 Buy
+9
New +$297 ﹤0.01% 4046
2026
Q1 		– Sell
-10
Closed -$351 – 4197
2025
Q4 		$351 Buy
+10
New +$364 ﹤0.01% 3946
2025
Q2 		– Sell
-7
Closed -$143 – 3855
2025
Q1 		$143 Buy
+7
New +$156 ﹤0.01% 3772

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

GAMMA Investing's NAMS Position: Q2 2026 in Review

GAMMA Investing opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 9 shares worth $305. The stake represents ﹤0.01% of the portfolio and ranks #4046 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in NAMS as recently as Q4 2025.

GAMMA Investing first reported a position in NAMS in Q1 2025 and has held it in 3 quarters since. The position peaked at $351 in Q4 2025. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • GAMMA Investing held 9 shares of NewAmsterdam Pharma worth $305 as of Q2 2026.
  • NewAmsterdam Pharma was a new GAMMA Investing position in Q2 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #4046 holding.
  • GAMMA Investing first reported a position in NewAmsterdam Pharma in Q1 2025 and has held it in 3 quarters since.
  • GAMMA Investing's NewAmsterdam Pharma position peaked at $351 in Q4 2025.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.